Suven Life Sciences Limited, a biopharmaceutical company provider of Contract Research and Manufacturing Services (CRAMS) for global life science companies, announced today that it has completed the previously disclosed purchase of the assets of Rising Pharmaceuticals and Rising's subsidiaries to Shore Suven Pharma, Inc.
"This brings closure of the purchase process for the assets of Rising Pharmaceuticals and paves the way for a seamless transition of the portfolio, customer programs and manufacturing and drug development relationships to Shore Suven Pharma Inc. which in turn will pave the way for continuity of product supply to the customers," said Mr. Venkat Jasti, CEO of Suven Life Sciences Ltd.
Shares of SUVEN LIFE SCIENCES LTD. was last trading in BSE at Rs.265.85 as compared to the previous close of Rs. 272.2. The total number of shares traded during the day was 19413 in over 496 trades.
The stock hit an intraday high of Rs. 271 and intraday low of 263.75. The net turnover during the day was Rs. 5201947.